Anja Pinborg

Anja Pinborg serves as a Clinical Professor at the University of Copenhagen's Department of Clinical Medicine, specializing in Obstetrics and Gynaecology. Her institutional affiliation with the Capital Region of Denmark (Region H) is reflected in her professional email domain, indicating dual academic-hospital responsibilities. With 325 documented research outputs, she maintains an active role in reproductive medicine research and clinical practice.

Her research primarily investigates assisted reproductive technologies (ART), focusing on comparative outcomes of fresh versus frozen embryo transfer, long-term health impacts on ART-conceived children, and fertility management for women with chronic conditions. Key interests include embryology kinetics, metabolic/bone development in offspring, and interdisciplinary approaches integrating neurology and endocrinology. Current projects emphasize real-world clinical applications and large-scale cohort analyses.

Recent publications (all 2025) reveal strong trends toward multi-center collaborative studies, prospective cohort designs, and systematic reviews addressing ART safety and efficacy. Her work spans clinical trials (INVICSI, NORSOS), nationwide registry studies, and European consensus initiatives through ESHRE. The research consistently prioritizes patient-centered outcomes across fertility treatment, pregnancy management, and child development.

Dr. Pinborg collaborates extensively across Danish hospitals and international networks, particularly within Nordic countries and Switzerland. Her leadership in studies like COMPART demonstrates integration of placental biology, maternal health, and offspring development. Current efforts focus on optimizing ART protocols while addressing comorbidities like multiple sclerosis, reflecting the field's shift toward personalized reproductive medicine.